```json
{
"content": [
{
"type": "paragraph",
content": "The Aortic Repair Devices ecosystem extends from nitinol and polyester yarn suppliers upstream, through stent-graft OEMs and coating technology licensors at midstream, to hospital catheterisation labs and aortic centres downstream. Value is created by converting raw alloys and biomaterials into CE-marked endovascular or surgical implants, captured via tender-based procurement, bundled procedure codes, and after-sales surveillance services."
},
{
"type": "list",
"title": null,
"items": [
{ "text": "Raw material/component suppliers — provide nitinol wire, ePTFE/PTFE grafts, delivery catheters", "level": 1 },
{ "text": "OEMs / manufacturers — design, laser-cut, assemble and sterilise stent-grafts or surgical grafts", "level": 1 },
{ "text": "Technology providers — license anti-migration coatings, fixation anchors, imaging software", "level": 1 },
{ "text": "Regulatory/notified bodies — conduct design dossier reviews, clinical site audits, post-market surveillance", "level": 1 },
{ "text": "Distributors/channel partners — manage hospital inventory, loaner sets, consignment stock", "level": 1 },
{ "text": "Service providers/after-sales — offer implant tracking, endoleak monitoring, staff training", "level": 1 },
{ "text": "End users/buyers — cardiac, vascular or cardiothoracic surgeons implanting in public or private hospitals", "level": 1 }
]
},
{
"type": "paragraph",
"content": "Adoption is gated by reimbursement approvals and hospital tender committees, while OEMs depend on single-source nitinol mills and polymer fibre suppliers, creating input volatility. Switching brands requires new imaging protocols, device-specific sizing tables and surgeon proctoring, locking centres into multi-year contracts. Regional divergence arises where public systems cap prices through tender lots, whereas U.S. IDNs leverage volume-based rebates; emerging markets rely on distributors to navigate import licences and local language labelling."
}
]
}
```
